The patient advocacy groups in India called for the incorporation of new cancer drugs into the NLEM,due to an increasing disparity between medical developments and public health care provisions
Indian healthcare sector transforms as pharmaceuticals step beyond traditional roles to make advanced treatments more accessible and affordable.
Telangana launches a new cancer drug plant, inaugurated by IT and Industries Minister Duddilla Sridhar Babu, which aims to boost the production of generic cancer drugs that will decrease the dependence on imports
India hosts the BRICS Heads in Guwahati, chaired by the Narcotics Control Bureau, and anti-drug agencies from BRICS nations to address the rising concerns over drug trafficking and substance abuse globally
Granules India secures first-to-file status for their drug Lumryz, which belongs to the complex generic drug category and is a cure for narcolepsy, a neurological disorder that affects the brain's ability to regulate sleep
NITI Aayog steps up to taking the indian traditional healthcare into global attention, with further evidence-based research and development, Ayurveda is expected to be popularised globally for its efficiency in preventive healthcare solutions.
India has introduced a major regulatory change for Stem Cell and Gene Therapy, bringing these advanced treatments under a central licensing framework.
Glenmark shares came under pressure after the US FDA issued six observations following an inspection of the company's Goa plant.
Telangana welcomes corporates by setting the ground for business and development for pharmaceuticals, GCCs, research institutions, and startups, taking a shift from implementing subsidies to being prominent in business and innovation
Aurobindo Pharma's Lannett Acquisition has officially entered a new phase with the successful completion of its USD 250 million buyout of US-based Lannett Company.
.jpg)
, CDSCO.jpg)
